For maintenance, ongoing use is required to preserve achieved results
BPC-157 targets inflammatory cytokines IL-1 and TNF- that drive endometriosis pain TB-500 promotes tissue repair and reduces adhesion formation in endometrial lesions Peptide therapy may reduce surgical intervention needs by 30-50% according to 2026 data Monthly treatment costs range from $180-400 for prescription peptide protocols Best results occur when combined with anti-inflammatory diet and stress management Understanding Endometriosis and Inflammatory Pathways Endometriosis creates a chronic inflammatory state in the pelvic cavity through multiple mechanisms
CagriSema submitted for FDA approval in December 2025 with expected approval in Q4 2026 or Q1 2027, meaning launch around mid-2027
Benefits: Supports healthy weight management goals Supports muscle wellness and active lifestyles Supports normal fat metabolism and energy production Supports overall metabolic wellness Ingredients: Vitamin C, Biotin, Magnesium, Glycine, Taurine, Carnitine, B Vitamins, 1L fluid Book Now Performance Pro $219 Performance Pro boosts post-workout recovery and performance
Cagrilintide Quick Start Cagrilintide is a once-weekly research peptide developed by Novo Nordisk